G CSF Administration for PBSC Collection and Its Link to IgA Nephropathy A Case Report

Introduction

Granulocyte-colony stimulating factor (G-CSF) is widely used for peripheral blood stem cell (PBSC) collection in stem cell donors. However, its potential to unmask pre-existing kidney conditions, such as IgA nephropathy (IgAN), remains an area of concern. A recent case study published in the Journal of Clinical Nephrology highlights the case of a 35-year-old donor who developed macrohematuria and proteinuria following PBSC donation, ultimately leading to an IgAN diagnosis four years later.

For more insights into groundbreaking nephrology research, visit HSPIOA.

Case Summary

The patient, a 35-year-old male, underwent PBSC donation after receiving G-CSF. Shortly after donation, he experienced episodes of dark urine (macrohematuria), which continued intermittently. Four years later, a routine check-up revealed proteinuria, hypertension, and IgAN diagnosis via kidney biopsy. Despite initial concerns, follow-up assessments showed stable kidney function, suggesting that PBSC collection did not worsen the pre-existing condition but possibly acted as a trigger for its manifestation.

Clinical Findings & Diagnosis

• Physical Examination: Normal except for elevated blood pressure 156/102 mmHg
• Urine Analysis: Proteinuria (100 mg/dl), albuminuria, and presence of erythrocytes.
• Blood Tests: Normal electrolytes, balanced acid-base status, and no autoimmune markers (ANA, ANCA, anti-GBM).
• Renal Biopsy: Confirmed early-stage IgAN with mild histological abnormalities.

Understanding the Link Between G-CSF and IgAN

Studies suggest that G-CSF may exacerbate underlying immune-mediated conditions, including IgAN, due to its immunomodulatory effects. While most PBSC donors tolerate the procedure well, rare cases of renal complications have been reported:

• Previous reports have linked G-CSF to cases of new-onset or exacerbated IgAN [1].
• Possible mechanisms: G-CSF-induced immune activation or endothelial damage may trigger hematuria in susceptible individuals [2].

Key Considerations for PBSC Donors

Given the low overall risk, PBSC donation remains a preferred method. However, pre-donation screening is recommended:
Medical History Review: Screen for family history of kidney disease.
Urinalysis & Kidney Function Tests: Detect early signs of renal issues.
Nephrologist Consultation: For donors with potential kidney conditions.

For full study details, access the original publication at DOI: 10.29328/journal.jcn.1001094.

Conclusion

This case highlights the importance of pre-donation screening for kidney disease in PBSC donors. While G-CSF remains safe for most, those with a predisposition to renal disorders should undergo careful evaluation before donation. Further research is needed to better understand the relationship between G-CSF and IgAN.

Stay Updated on Nephrology Research!

Explore more studies at HSPIOA and share your thoughts in the comments below!

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article